Bénédicte Brounais-Le Royer

Author

Also Known As

B Royer, B. Brounais-Le Royer, B. Brounais-Le Royer⁎, B. Royer, Benedicte Brounais-Le Royer, Benedicte Royer, Bénédicte Brounais-Le Royer, Bénédicte Royer

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Inserm Sorbonne Université Nantes Université Pitié-Salpêtrière Hospital University of Sheffield

About

Bénédicte Brounais-Le Royer is an author at Inserm specializing in medicine, autoimmunity, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	233
2	Cell Biology	2	2	66
3	Engineering	1	1	12
4	Allergy	1	1	10
5	Biomedical Engineering	1	1	12

Bénédicte Brounais-Le Royer

Publications

807

Citations

H-Index

Page 1

	Year	Citations
Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography Gilles Russ, Bénédicte Brounais-Le Royer, C. Bigorgne, European Journal of Endocrinology	2013	322
Oncostatin M, an Inflammatory Cytokine Produced by Macrophages, Supports Intramembranous Bone Healing in a Mouse Model of Tibia Injury Pierre Guihard, Marie‐Astrid Boutet, Bénédicte Brounais-Le Royer, American Journal Of Pathology InflammationCytokineTibia InjuryOncostatin MAnti-inflammatory	2015	145
A multicentre validation study for the EU‐TIRADS using histological diagnosis as a gold standard Pierpaolo Trimboli, Rose Ngu, Bénédicte Brounais-Le Royer, Clinical Endocrinology	2019	60
TIRADS score is of limited clinical value for risk stratification of indeterminate cytological results Emmanuelle Chaigneau, Gilles Russ, Bénédicte Brounais-Le Royer, European Journal of Endocrinology	2018	54
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619 Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye, Cells SclerostinPathologyCancer BiologyTumor BiologyBone Morphogenic Protein	2021	43
The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth Sarah Morice, Mathilde Mullard, Régis Brion, Cancers	2020	41
Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression Benjamin Ory, Marc Baud’huin, Franck Verrecchia, Clinical Cancer Research	2015	36
Value of the cytological diagnosis in the treatment of parotid tumors Alice Jafari, Bénédicte Brounais-Le Royer, M. Lefèvre, Otolaryngology	2009	32
ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells Geoffroy Danieau, Sarah Morice, Sarah Renault, Pharmaceuticals Osteosarcoma CellsCancer BiologyTumor BiologyOsteosarcoma Mouse ModelTranscriptional Regulation	2021	23
Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis Sarah Morice, Geoffroy Danieau, Robel Tesfaye, Frontiers in Oncology	2021	16

Page 1